✦ LIBER ✦

Efficacy of Novel Syk-Kinase Inhibitors MT-SYK-03 and MT-SYK-322 in Cellular Models of Autoimmunity and Cancer

✍ Scribed by Rakitina, Tatiana V.; Zeifman, Alexey A.; Titov, Ilya Yu.; Svitanko, Igor V.; Lipkin, Aleksey V.; Stroylov, Viktor S.; Stroganov, Oleg V.; Novikov, Fedor N.; Chilov, Ghermes G.

Book ID: 119325102
Publisher: Royal Society of Chemistry
Year: 2012
Tongue: English
Weight: 348 KB
Volume: 22
Category: Article
ISSN: 0959-9436
DOI: 10.1016/j.mencom.2012.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Selective inhibition of spleen tyrosine

Selective inhibition of spleen tyrosine kinase (SYK) with a novel orally bioavailable small molecule inhibitor, RO9021, impinges on various innate and adaptive immune responses: implications for SYK inhibitors in autoimmune disease therapy

✍ Liao, Cheng; Hsu, Jonathan; Kim, Yong; Hu, Dong-Qing; Xu, Daigen; Zhang, Jun; Pa 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 893 KB

Characterization of a Novel, Potent and

Characterization of a Novel, Potent and Selective Small Molecule Spleen Tyrosine Kinase (SYK) Inhibitor in In Vitro and In Vivo Models of Asthma.

✍ Crackower, M.A.; Moy, L.Y.; Jia, Y.; Yu, H.; Vincent, S.; Miller, J.R.; Lieber, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB